Skip to main content
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD logo

BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD — Investor Relations & Filings

Ticker · 000931 ISIN · CNE000001030 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,999 across all filing types
Latest filing 2024-04-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000931

About BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD

https://www.centek.com.cn

Beijing Centergate Technologies (Holding) Co., Ltd. focuses on the research, development, production, and distribution of medical and healthcare products. The company’s core operations involve the manufacturing of chemical pharmaceuticals, traditional Chinese medicines, and health supplements. Its product portfolio addresses various therapeutic areas, including cardiovascular health, digestive system treatments, and anti-infective therapies. Additionally, the company provides healthcare services and develops medical devices. Through its specialized subsidiaries, it maintains integrated research and manufacturing capabilities aimed at providing clinical solutions and health management products. The organization emphasizes technological advancement and quality control across its supply chain to meet diverse patient needs and healthcare standards.

Recent filings

Filing Released Lang Actions
关于多多药业2024年度预计主要日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is titled as an announcement regarding the 2024 annual expected major daily related party transactions of a company. It details the nature, pricing, contracts, and expected amounts of transactions between the company and a related party (a shareholder with 20.98% stake). It includes contract terms, pricing policies, and independent directors' opinions on the fairness of the transactions. The document is an announcement of expected related party transactions for the year 2024, not a financial report or audit. It is a regulatory disclosure about related party transactions, which is a typical regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a voting result, board change, or legal proceeding. It is not a report publication announcement since it contains substantive content and is longer than 5,000 characters. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements including related party transaction disclosures.
2024-04-18 Chinese
关于2023年度利润分配预案公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as a "2023年度利润分配预案公告" which translates to "2023 Annual Profit Distribution Proposal Announcement." It details the company's board and supervisory board meetings approving a profit distribution plan for the year 2023, specifically stating that no profit distribution or capital reserve conversion to shares will be made due to accumulated losses. The document is short (1384 characters) and serves as an announcement of the profit distribution proposal rather than a full financial report or detailed dividend notice. It does not provide dividend amounts or payment dates but rather the proposal and rationale for no distribution. This fits best with the category of Notice of Dividend Amount (DIV) or a related dividend announcement. However, since it explicitly states a profit distribution proposal (which is closely related to dividend announcements) and includes the board's approval and submission to the shareholders' meeting, it aligns most closely with the Notice of Dividend Amount (DIV) category, which covers announcements of dividend amounts, payment dates, and related details for shareholders, including announcements of no dividend.
2024-04-18 Chinese
年度募集资金使用情况专项说明
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023年度募集资金存放与使用情况专项报告" which translates to "2023 Annual Special Report on the Storage and Use of Raised Funds". It details the use and management of funds raised through a non-public stock issuance approved by the China Securities Regulatory Commission. The report includes extensive financial data on the raised funds, their allocation, usage progress, project investment details, and compliance with regulatory requirements. It is a specialized report focusing on the use of capital raised by the company, not a general annual report or earnings release. This type of document fits the category of Capital/Financing Update (CAP), as it provides updates on the company's fundraising and the use of those funds. The document is comprehensive and contains substantive financial data related to capital usage, not merely an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2024-04-18 Chinese
审计委员会工作细则（2024年4月）
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会工作细则' which translates to 'Board Audit Committee Working Rules'. It details the structure, responsibilities, decision-making procedures, and meeting rules of the Audit Committee under the Board of Directors of the company. It does not contain financial statements, audit opinions, or results of audits, nor does it report on financial performance or regulatory compliance results. Instead, it is a governance document outlining internal rules and procedures related to the audit committee's function within the board. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3923 characters, which is sufficient for a detailed governance report. Therefore, the appropriate classification is CGR with high confidence.
2024-04-18 Chinese
2023年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2023 年度董事会工作报告' which translates to '2023 Annual Board of Directors Work Report'. It contains a detailed summary of the company's business activities, financial performance, strategic plans for 2024, and the operation of the board of directors during 2023. It includes comprehensive information about the company's operations, financial results, board meetings, committee activities, and investor relations. The length of the document (11,676 characters) and the detailed content indicate it is a full report rather than a brief announcement. The focus on the board's work and detailed operational and strategic information aligns with the category of Board/Management Information (MANG). It is not an annual report (10-K) because it lacks full financial statements and audit details, nor is it a regulatory filing or announcement. Therefore, the document is best classified as Board/Management Information (MANG).
2024-04-18 Chinese
股东大会议事规则（2024年4月）
Governance Information Classification · 95% confidence The document is titled '股东大会议事规则' which translates to 'Rules of Procedure for the Shareholders' General Meeting'. It details the rules, procedures, powers, and responsibilities related to the company's shareholders' meetings, including how meetings are convened, voting procedures, proposal submissions, and legal compliance. It is a governance document outlining internal rules and practices for shareholder meetings rather than a report of financial results, announcements, or meeting minutes. It does not contain financial statements, audit opinions, or voting results but rather the framework governing shareholder meetings. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-04-18 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.